SCHEMBL20737740

SCHEMBL20737740

Cn1c(-c2ccc(-c3ccc4c5c(ccc4c3)-c3cc4ccccc4cc3C53c4ccccc4-c4ccccc43)cc2)nc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.45
RAB9A P51151 6/20 0.45
ALDH1A1 P00352 6/20 0.45
NPC1 O15118 5/20 0.45
HSD17B10 Q99714 4/20 0.45
PKM P14618 3/20 0.45
TP53 P04637 3/20 0.45
GAA P10253 3/20 0.45
ALOX15 P16050 1/20 0.45
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
GFER P55789 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20736546 0.95 RAB9A (0.44) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20737104 0.95 KDM4E (0.41) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20736487 0.91 PDE10A (0.41) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20737107 0.91 ALDH1A1 (0.44) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20737747 0.91 KDM4E (0.41) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20737724 0.89 KDM4E (0.51) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20737742 0.88 KDM4E (0.48) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20737741 0.88 KDM4E (0.47) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20737261 0.87 PDE10A (0.41) KDM4ERAB9AALDH1A1NPC1HSD17B10
SCHEMBL20735586 0.86 KDM4E (0.41) KDM4ERAB9AALDH1A1NPC1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885RAB9A 1517/4885ALDH1A1 125/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 KDM4E 2169/4885RAB9A 1517/4885ALDH1A1 125/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 KDM4E 2169/4885RAB9A 1517/4885ALDH1A1 125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.